Mertens J J, Gibson N W, Lau S S, Monks T J
Division of Pharmacology and Toxicology, College of Pharmacy, University of Texas at Austin 78712, USA.
Arch Biochem Biophys. 1995 Jun 20;320(1):51-8. doi: 10.1006/abbi.1995.1341.
Exposure of renal proximal tubular epithelial cells (LLC-PK1) to the nephrotoxicants 2-bromo-6-(glutathion-S-yl)hydroquinone, 2-bromo-3-(glutathion-S-yl)-hydroquinone, and 2-bromo-(diglutathion-S-yl)hydroquinone caused DNA fragmentation and cytotoxicity. Viability measured by lysosomal neutral red accumulation was the most sensitive parameter of cytotoxicity, and preceded toxicity determined by either the mitochondrial MTT assay or by measuring intracellular lactate dehydrogenase activity. DNA fragmentation was detected as early as 15 min after exposure to 2-bromo-6-(glutathion-S-yl)hydroquinone (100 microM), 2-bromo-3-(glutathion-S-yl)hydroquinone (200 microM), and 2-bromo-(diglutathion-S-yl)hydroquinone (400 microM) and prior to other indices of toxicity. The ability of the cells to repair DNA damage was evident by the decrease in the extent of single strand breaks following removal of 2-bromo-3-(glutathion-S-yl)hydroquinone from the incubation medium. Moreover, inhibition of poly(ADP-ribose)polymerase with 3-amino-benzamide (10 mM), following exposure of LLC-PK1 cells to 0.5 mM 2-bromo-6-(glutathion-S-yl)hydroquinone or 2-bromo-(diglutathion-S-yl)hydroquinone, decreased cytotoxicity, indicating that DNA repair processes, activated in response to DNA damage, exacerbate toxicity. Treatment with the endonuclease inhibitor, aurintricarboxylic acid did not decrease cytotoxicity. A decrease in the cytotoxicity caused by 2-bromo-6-(glutathion-S-yl)hydroquinone and 2-bromo-(diglutathion-S-yl)hydroquinone was observed when cells were incubated with catalase or pretreated with deferoxamine (10 mM). The data suggest a mechanism whereby the conjugates generate hydrogen peroxide, and the subsequent iron-catalyzed generation of hydroxyl radicals causes DNA fragmentation and cytotoxicity.
将肾近端小管上皮细胞(LLC-PK1)暴露于肾毒性物质2-溴-6-(谷胱甘肽-S-基)对苯二酚、2-溴-3-(谷胱甘肽-S-基)对苯二酚和2-溴-(双谷胱甘肽-S-基)对苯二酚会导致DNA片段化和细胞毒性。通过溶酶体中性红积累测定的细胞活力是细胞毒性最敏感的参数,且先于通过线粒体MTT法或测量细胞内乳酸脱氢酶活性所确定的毒性。在暴露于2-溴-6-(谷胱甘肽-S-基)对苯二酚(100 microM)、2-溴-3-(谷胱甘肽-S-基)对苯二酚(200 microM)和2-溴-(双谷胱甘肽-S-基)对苯二酚(400 microM)后15分钟就检测到了DNA片段化,且早于其他毒性指标。从孵育培养基中去除2-溴-3-(谷胱甘肽-S-基)对苯二酚后,单链断裂程度降低,这表明细胞具有修复DNA损伤的能力。此外,在LLC-PK1细胞暴露于0.5 mM 2-溴-6-(谷胱甘肽-S-基)对苯二酚或2-溴-(双谷胱甘肽-S-基)对苯二酚后,用3-氨基苯甲酰胺(10 mM)抑制聚(ADP-核糖)聚合酶可降低细胞毒性,这表明响应DNA损伤而激活的DNA修复过程会加剧毒性。用核酸内切酶抑制剂金精三羧酸处理并没有降低细胞毒性。当细胞与过氧化氢酶一起孵育或用去铁胺(10 mM)预处理时,观察到2-溴-6-(谷胱甘肽-S-基)对苯二酚和2-溴-(双谷胱甘肽-S-基)对苯二酚所引起的细胞毒性降低。数据表明了一种机制,即这些共轭物会产生过氧化氢,随后铁催化产生的羟基自由基会导致DNA片段化和细胞毒性。